Therefore, the diet and formulation that distend gut and release GLP-1 may provide a new evidence-based diet therapy to treat arrhythmic overeating, obesity, and diabetes. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.